Σύγκριση μεθόδων

	Πειραματικός Σχεδιασμός Διασταυρούμενης Μέτρησης Προ-Ελέγχου-Μετα-Ελέγχου	Σχεδιασμός τυχαιοποιημένης ελεγχόμενης δοκιμής με διασταύρωση
Πεδίο	Πειραματικός Σχεδιασμός	Πειραματικός Σχεδιασμός
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1963 (Campbell & Stanley framework); crossover methodology formalized 1980s–2000s	1960s (Grizzle 1965 for statistical foundations); widely used in clinical research since the 1970s
Δημιουργός	Donald T. Campbell & Julian C. Stanley (pretest-posttest framework); Stephen Senn (crossover trial methodology)	Early formalized by statisticians including Bradford Hill and colleagues in clinical trials; theoretical framework developed by Grizzle (1965) and later Senn (2002)
Τύπος	Within-subjects experimental design	Experimental within-subject design
Θεμελιώδης πηγή	Senn, S. (2002). Cross-over Trials in Clinical Research (2nd ed.). Wiley. ISBN: 978-0471496533	Senn, S. (2002). Cross-over Trials in Clinical Research (2nd ed.). Wiley. ISBN: 978-0471496533
Εναλλακτικές ονομασίες	within-subjects pretest-posttest design, repeated-measures crossover design, AB/BA pretest-posttest design, crossover repeated-measures design	crossover RCT, crossover trial, within-subject RCT, AB/BA crossover design
Συναφείς	5	5
Σύνοψη	A crossover pretest-posttest experimental design is a within-subjects experiment in which each participant receives two or more treatments in a randomized sequence, with outcome measurements taken both before and after each treatment period. By serving as their own control across conditions, participants allow direct intra-individual comparison, dramatically increasing statistical power while reducing the sample size required relative to a parallel-group design.	A crossover randomized controlled trial (crossover RCT) is an experimental design in which each participant receives all study interventions in a randomized sequence, separated by a washout period. Because every participant serves as their own control, within-subject variability is eliminated from the treatment comparison, yielding greater statistical power per participant than a parallel-group RCT of equal size.